A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma

Trial Identifier: CAT-354-0602
Sponsor: MedImmune, LLC
NCTID:: NCT00974675
Start Date: September 2006
Primary Completion Date: August 2007

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Kingdom, Berkshire Slough, Berkshire, United Kingdom, SL1 2AD